University of Michigan, Ann Arbor;
University of Rochester, Rochester, NY
Objective: To assess tumor markers in advanced laryngeal cancer.
Design: Marker expression and clinical outcome.
Patients: Tissues from 112 patients of the Veterans Affairs laryngeal cancer trial were analyzed: 42 from the chemotherapy arm and 70 from the surgical arm of the study.
B. Kumar, K. G. Cordell, N. D'Silva, M. E. Adams, S. G. Fisher, G. T. Wolf, T. E. Carey, C. R. Bradford. S024 Expression of p53 and Bcl-xL as Predictive Markers for Larynx Preservation in Advanced Laryngeal Cancer. Arch Otolaryngol Head Neck Surg. 2006;132(8):843–844. doi:10.1001/archotol.132.8.843-c
* * Maintenance Notice * *
Maintenance will be performed from 11:00pm CT December 16, 2017 to 4:00pm CT December 17. Please be advised that your site/services may be periodically unavailable during this maintenance window.